Our finding that 26% of primary TNBC express PD-L1 on the cancer cell surface is consistent with the findings of Mittendorf et al. 27 who reported that 19% of 105 primary TNBC showed cancer cell PD-L1 positivity. The gene discussed is CD274; the disease is cancer.